Tech Mahindra Accelerates Enterprise AI Transformation with Gemini Enterprise

The collaboration combines Tech Mahindra's extensive implementation experience, AI-first engineering talent, and proven Orion framework with Google Cloud's advanced AI capabilities to help organizations design, deploy, and scale next-generation Agentic AI solutions. Gemini Enterprise will also enable the creation of specialized AI agents, embed governance and safety guardrails, and integrate them seamlessly with Google Cloud's ecosystem, including Google Cloud's Vertex AI platform, Google BigQuery, and advanced data-to-AI pipelines.
As a Google Cloud Premier Partner, Tech Mahindra brings strong implementation credentials aligned with its 'AI Delivered Right' strategy. The AI adoption strategy emphasizes four key pillars, including Transformation Delivered, Productivity Delivered, Innovation Delivered, and Assurance Delivered, ensuring AI is embedded into enterprise processes with trust, governance, and business-aligned impact.
Tech Mahindra has further strengthened its capabilities through dedicated Centers of Excellence, a portfolio of ready-to-deploy Agentic AI solutions, and a certified talent pool skilled in Google Cloud AI technologies. Together, the organizations will enable enterprises to move confidently toward an Agentic AI-powered future, where connected, reasoning agents deliver business outcomes with speed, precision, and purpose.
Our Website & Social Media Channels
Website | LinkedIn | X
Logo: https://mma.prnewswire.com/media/2804444/5688431/Tech_Mahindra_New_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/tech-mahindra-accelerates-enterprise-ai-transformation-with-gemini-enterprise-302645549.html
SOURCE Tech Mahindra
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
- Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
- HydraOS Adds Slack-Based Agent Layer With 4 Specialized Agents
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share